Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

No longer available 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Keratosis, Actinic 14Carcinoma, Basal Cell 7Bowen's Disease 2Warts 1Skin Neoplasms 1Skin Diseases 1Neoplasms, Basal Cell 1Keratosis 1Connective Tissue Diseases 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

methyl 5-aminolevulinate 2Tomography, Optical Coherence 1SR-T100 1Photochemotherapy 1Cryotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bowen's Disease × methyl 5-aminolevulinate × Dermatologic × Clear all
NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed
82 enrolled 20 charts
Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

NCT00535080 2021-02-18

Compassionate Use of Metvix® (Methyl Aminolevulinate) Photodynamic Therapy (PDT) in Subjects With Field Actinic Keratoses, Large/Multiple Superficial Basal Cell Carcinomas (BCCs), or Bowen's Disease

Galderma R&D

No longer available
Dermatologic

Bowen's Disease, Carcinoma, Carcinoma, Basal Cell, Keratosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡